Avantor, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-12-31 was $0.00.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $0.00.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $0.00.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2019-12-31 was $0.00.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $0.00.
- Avantor, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $1.56B.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $0.00 10-K · filed 2025-02-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-07-28 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $1.56B 10-K · filed 2022-02-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | |
| 2019-06-30 | $1.56B 10-Q · filed 2020-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |